Influential doctors aren’t disclosing their drug company ties

Ray N Moynihan, Lisa Bero

Research output: Contribution to journalOnline ResourceEducation

Abstract

In September, the New York Times revealed that one of the world’s top cancer specialists had quietly received millions of dollars from drug and other companies. And what’s more, he’d failed to disclose the payments in many of his high-profile medical journal articles.

A few months before that, a study found that many experts who write medical textbooks received company payments, but again, their readers didn’t know about it.
Original languageEnglish
JournalThe Conversation
Publication statusPublished - 5 Feb 2019

Fingerprint

Dive into the research topics of 'Influential doctors aren’t disclosing their drug company ties'. Together they form a unique fingerprint.

Cite this